Patent · US Active

Inhalation device

US10632268B2 · kind B2 · utility

3Cited by
86References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2014
Grant dateApr 28, 2020
Priority date
Expiry dateJun 30, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/07
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The integration of drug dispersion methods into a drug or medicine delivery system may use shear (e.g., air across a drug, with or without a gas assist), capillary flow or a venturi effect, mechanical means such as spinning, vibration, or impaction, and turbulence (e.g., using mesh screens, or restrictions in the air path). These methods of drug dispersion allow for all of the drug in the system to be released, allowing control of the dosage size. These methods also provide for drug metering, fluidization, entrainment, deaggragation and deagglomeration. The integration of a drug sealing system into the device provides a way of blocking the migration of drug from one area of the package to another. The drug seal system can also provide a method of tightly containing the drug until the package is opened, of directing airflow through the package and of managing and containing the drug during the package/device manufacturing process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.